Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition. - Wikidata - awgldk - TriplyDB

Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.

Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.

http://www.wikidata.org/entity/Q37222197

about

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

P2860

Q56594845-38B30E75-1B33-4EA8-8209-F2C276904E44

P2860

Myeloid PTEN deficiency impairs tumor-immune surveillance via immune-checkpoint inhibition.

http://www.wikidata.org/entity/Q37222197

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 March 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@en

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@nl

type

label

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@en

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@nl

prefLabel

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@en

Myeloid PTEN deficiency impair ...... immune-checkpoint inhibition.

@nl

P1433

Q37222197-B672F9BF-AD20-49F2-BFAD-662C1A35E560

P1476

Q37222197-0719C24B-C917-4522-B717-4B934F362042

P2093

Q37222197-011D3356-2688-42EF-B103-8E92EE10FC68

Q37222197-248AE80E-7835-450D-8AE7-947F0BB655DA

Q37222197-3BD173F1-5AA0-4BCA-99CB-B97FFFE250A0

Q37222197-5599A0B3-4869-4823-B348-CCCB14109F5E

Q37222197-57D72C2C-4799-40D0-AB58-812393E2ABB6

Q37222197-6B434A05-6615-4D8D-993C-D44BEDA4EAF7

Q37222197-7BDA2097-15FE-4B4A-A032-EEC864FF5EFA

Q37222197-838A93F6-75EA-40C1-91FB-49CC0AB548CE

Q37222197-88AB06D9-86F0-4FCC-A6EC-D5E82150D02A

Q37222197-CC49706E-A5F5-4A71-BC7C-C58F03920938

P2860

Q37222197-08F98299-9CED-4D34-9DF5-09C2424FA590

Q37222197-0975B130-4310-4186-96D6-186E3FA03604

Q37222197-0DD8C7DC-8C45-4560-81E2-D001A82633EC

Q37222197-16877B93-461F-44FA-9982-485581382504

Q37222197-1B7BE663-1505-43A7-9B0B-8A1D32B559E9

Q37222197-1EC8205E-F637-4B07-8F36-9B9F69629008

Q37222197-1FCAE7E1-35D4-4E7B-A36A-A2BA5533B44C

Q37222197-22D2E98B-D080-4864-AF78-A55B58036939

Q37222197-264503F3-7E00-4FBD-9334-32A41CD7A46D

Q37222197-279880BC-6BB2-4AF4-A531-5EF849EAD176

P304

Q37222197-2E4679BB-BABD-4FCA-A199-1E6D89D6D454

P31

Q37222197-1A00CF2B-816F-4184-A560-2BE8EEA90E4A

P356

Q37222197-6C327BF4-3F52-4D30-85B9-4009952D9DB2

P433

Q37222197-2C1178FC-9F3A-4FAB-9D1F-2543F2C1AC7F

P478

Q37222197-001022FA-258F-4BE0-B529-3C6EE58C6896

P50

Q37222197-174F8B25-86F4-43BD-847D-5184B52FC349

Q37222197-229D28CE-1697-4049-AC50-071AB63C11DC

Q37222197-23A2BC49-2C18-4563-AA24-C501C4AC81FD

Q37222197-4B8BFEF1-350F-41EF-B7CF-0AC3990D71AF

Q37222197-5066CEF8-C97E-4AA1-A19D-0FFF817C7303

Q37222197-68A53185-673A-4A81-8DA9-AFABD870670A

Q37222197-7745AABC-07FB-4924-8447-302BB2448614

Q37222197-815E34DE-3DB4-4CBE-8BB3-B57D4F0CB199

Q37222197-A18780B5-0801-4005-A637-196464A7999A

Q37222197-BCB30B2C-7C17-490F-AFDB-4C48A6B2F707

P577

Q37222197-0C3EC715-FA85-4E78-8A59-2F7D3B975783

P698

Q37222197-37AD7E04-E479-4F3C-9001-8245051142FE

P932

Q37222197-271A0976-3C20-4C68-A805-20C9D0AD5C7D

P356

2162402X.2016.1164918

P1433

P1476

Myeloid PTEN deficiency impair ...... a immune-checkpoint inhibition

@en

P2093

A Halfmann

http://www.w3.org/2001/XMLSchema#string

A Vogel

http://www.w3.org/2001/XMLSchema#string

C W Steiner

http://www.w3.org/2001/XMLSchema#string

D Kraemmer

http://www.w3.org/2001/XMLSchema#string

E Sahin

http://www.w3.org/2001/XMLSchema#string

G Lametschwandtner

http://www.w3.org/2001/XMLSchema#string

G Schabbauer

http://www.w3.org/2001/XMLSchema#string

H Paar

http://www.w3.org/2001/XMLSchema#string

J Pisoni

http://www.w3.org/2001/XMLSchema#string

L Hanzl

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein

Immune tolerance after delivery of dying cells to dendritic cells in situ

PD-L1 and PD-L2 are differentially regulated by Th1 and Th2 cells

Dextran sodium sulphate colitis mouse model: traps and tricks

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

The phosphoinositide 3-kinase pathway

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

P304

e1164918

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/2162402X.2016.1164918

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Michael Dohnal

Johannes A. Schmid

Manuel Salzmann

Bernhard Hochreiter

P577

2016-03-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27622019

http://www.w3.org/2001/XMLSchema#string

P932

5006931

http://www.w3.org/2001/XMLSchema#string